Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0000950170-25-068281

Chief Financial Officer bought 8,462 shares at $26.00 ($220,012)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Byam Rebecca Chief Financial Officer 2025-05-08 Purchase +8,462 $26.00 $220,012 43,010 D: show line 1 in the form
Open-market purchases · 8,462 sh · avg $26.00 · $220,012

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Byam Rebecca Chief Financial Officer 2025-05-07 Purchase · Common Stock Purchase Warrant +4,231 4,231 D: show line 2 in the form
Loading xslF345X05/ownership.xml…